Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial.

Circ Genom Precis Med · 2022 · PMC9213083 · PMID 35543701

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP =6.01×10 −9actually significant

This variant in TMEM9 (rs6667912) was also highly significant in the European subgroup analysis (odds ratio [95% CI], 1.39 [1.24–1.55]; P =6.01×10 −9 ; Figure S2 ) and was significantly associated with a skeletal muscle splicing quantitative trait loci in TMEM9 23 ( P =1.1×10 −8 ; Table S2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.